ATE264839T1 - Amino-thiolester-verbindungen, diese enthaltende pharmazeutische und kosmetische zusammensetzungen und ihre anwendungen - Google Patents
Amino-thiolester-verbindungen, diese enthaltende pharmazeutische und kosmetische zusammensetzungen und ihre anwendungenInfo
- Publication number
- ATE264839T1 ATE264839T1 AT01940654T AT01940654T ATE264839T1 AT E264839 T1 ATE264839 T1 AT E264839T1 AT 01940654 T AT01940654 T AT 01940654T AT 01940654 T AT01940654 T AT 01940654T AT E264839 T1 ATE264839 T1 AT E264839T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical
- amino
- compositions containing
- cosmetic compositions
- containing same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/22—Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007029A FR2809727B1 (fr) | 2000-05-31 | 2000-05-31 | Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
PCT/FR2001/001694 WO2001092220A1 (fr) | 2000-05-31 | 2001-05-31 | Composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE264839T1 true ATE264839T1 (de) | 2004-05-15 |
Family
ID=8850863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01940654T ATE264839T1 (de) | 2000-05-31 | 2001-05-31 | Amino-thiolester-verbindungen, diese enthaltende pharmazeutische und kosmetische zusammensetzungen und ihre anwendungen |
Country Status (10)
Country | Link |
---|---|
US (1) | US8026231B2 (de) |
EP (1) | EP1296946B1 (de) |
JP (1) | JP4855626B2 (de) |
AR (1) | AR028122A1 (de) |
AT (1) | ATE264839T1 (de) |
AU (1) | AU2001274171A1 (de) |
DE (1) | DE60102925T2 (de) |
ES (1) | ES2219530T3 (de) |
FR (1) | FR2809727B1 (de) |
WO (1) | WO2001092220A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2983492B1 (fr) * | 2011-12-06 | 2015-10-30 | Advanced Biodesign | Procede ex vivo de purge tumorale d'un echantillon biologique |
ES2870508T3 (es) | 2015-10-15 | 2021-10-27 | Advanced Biodesign | Combinación que comprende un compuesto de aminotioléster o una sal farmacéuticamente aceptable del mismo y un compuesto capaz de aumentar el nivel de H2O2 en células cancerosas de un sujeto |
JP7062593B2 (ja) | 2015-10-15 | 2022-05-06 | アドヴァンスト・バイオデザイン | 癌治療への使用のための、アミノチオールエステル化合物、またはその薬学的に許容される塩 |
FR3047734B1 (fr) * | 2016-02-17 | 2019-09-06 | Advanced Biodesign | Procede de preparation de composes aminothiolester et leurs sels |
EP3833657B1 (de) * | 2019-07-31 | 2022-07-27 | Advanced Biodesign | Aminothiolesterverbindungen und verwendungen davon |
FR3119314A1 (fr) | 2021-01-29 | 2022-08-05 | Advanced Biodesign | Nanocapsule lipidique comprenant au moins un composé aminothiolester ou un de ses dérivés pharmaceutiquement acceptable |
EP4035666A1 (de) | 2021-01-29 | 2022-08-03 | Advanced Biodesign | Aminothiolesterverbindung oder derivate davon zur verwendung als immunmodulatorisches mittel |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5051528A (en) | 1990-04-24 | 1991-09-24 | Eastman Kodak Company | Recovery process for ethylene glycol and dimethylterephthalate |
JPH0797350A (ja) * | 1993-08-02 | 1995-04-11 | Mitsubishi Chem Corp | ベンゾイルアセチレン誘導体 |
FR2761606B1 (fr) * | 1997-04-08 | 1999-05-14 | Cird Galderma | Utilisation de derives aminothiolesters dans le domaine pharmaceutique |
WO1999028285A1 (en) | 1997-12-02 | 1999-06-10 | Heinrich Smuda | Method of recovery of terephthalic acid and ethylene glycol from poly/ethylene terephthalate/wastes |
FR2777001B1 (fr) * | 1998-04-01 | 2000-06-09 | Cird Galderma | Derives de l'acide 6,8-dimercaptooctanoique substitues en 6-s et/ou en 8-s par le radical (3-methylthiopropanoyl) et compositions pharmaceutiques destinees au traitement des tumeurs cancereuses |
MXPA02003928A (es) | 1999-10-22 | 2002-10-23 | Teijin Ltd | Metodo para la separacion y recuperacion de tereftalato de dimetilo y etilenglicol a partir de residuo de poliester. |
JP3808672B2 (ja) | 1999-11-26 | 2006-08-16 | 東洋製罐株式会社 | 回収ポリエチレンテレフタレート粉砕品からのテレフタル酸の工業的回収方法 |
-
2000
- 2000-05-31 FR FR0007029A patent/FR2809727B1/fr not_active Expired - Fee Related
-
2001
- 2001-05-30 AR ARP010102577A patent/AR028122A1/es unknown
- 2001-05-31 EP EP01940654A patent/EP1296946B1/de not_active Expired - Lifetime
- 2001-05-31 JP JP2002500835A patent/JP4855626B2/ja not_active Expired - Lifetime
- 2001-05-31 AT AT01940654T patent/ATE264839T1/de not_active IP Right Cessation
- 2001-05-31 DE DE60102925T patent/DE60102925T2/de not_active Expired - Lifetime
- 2001-05-31 AU AU2001274171A patent/AU2001274171A1/en not_active Abandoned
- 2001-05-31 ES ES01940654T patent/ES2219530T3/es not_active Expired - Lifetime
- 2001-05-31 WO PCT/FR2001/001694 patent/WO2001092220A1/fr active IP Right Grant
-
2006
- 2006-03-28 US US11/390,480 patent/US8026231B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP1296946A1 (de) | 2003-04-02 |
DE60102925T2 (de) | 2005-04-07 |
FR2809727B1 (fr) | 2002-07-26 |
DE60102925D1 (de) | 2004-05-27 |
FR2809727A1 (fr) | 2001-12-07 |
US8026231B2 (en) | 2011-09-27 |
US20070032476A1 (en) | 2007-02-08 |
WO2001092220A1 (fr) | 2001-12-06 |
AU2001274171A1 (en) | 2001-12-11 |
ES2219530T3 (es) | 2004-12-01 |
JP4855626B2 (ja) | 2012-01-18 |
EP1296946B1 (de) | 2004-04-21 |
JP2003535076A (ja) | 2003-11-25 |
AR028122A1 (es) | 2003-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE478840T1 (de) | 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung | |
ATE309206T1 (de) | Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen | |
EE05183B1 (et) | Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon | |
EE05475B1 (et) | Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon | |
DE60138872D1 (de) | Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
DE50214263D1 (de) | Emollients und kosmetische zusammensetzungen enthaltend 2-methyl-1,3-propandioldiester | |
DE60219051D1 (de) | Pyrimidonverbindungen und pharmazeutische zusammensetzungen, die diese enthalten | |
NO20025450L (no) | Ny farmasöytisk sammensetning | |
DE60209929D1 (de) | Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen | |
HUP0700086A2 (en) | 2-aminopyridine compounds, use thereof as drugs and pharmaceutical compositions containing them | |
DE69900455T2 (de) | Feste kosmetische Zubereitung und ihre Anwendungen | |
IL163552A (en) | Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same | |
DE50211581D1 (de) | Tensidefreie kosmetische, dermatologische und pharmazeutische Mittel | |
FR2795324B1 (fr) | Compositions pharmaceutiques stabilisees | |
BR0014526B1 (pt) | compostos cíclicos de seis elementos contendo nitrogênio aromático, composição farmacêutica e uso do mesmo | |
FI991485A (fi) | Uusi farmaseuttinen koostumus | |
AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
DE69802615T2 (de) | Triaromatische Verbindungen, diese enthaltende Zusammensetzungen sowie ihre Anwendungen | |
DE69927033T2 (de) | 4-aminopyridinderivate, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen | |
ATE343373T1 (de) | Kosmetische zusammensetzungen enhaltend ein vinyldimethicon/dimethicon copolymer und ein konditionierungsmittel, und ihre anwendungen | |
DE60217783D1 (de) | Filmbildende Zusammensetzung, enthaltend Sucralose und Hydrocolloid | |
EE200200281A (et) | Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks | |
ATE277006T1 (de) | (poly)thia-alkin-verbindungen und ihre derivate, diese enthaltende zusammensetzungen und ihre anwendung | |
ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
ATE204266T1 (de) | Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1296946 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |